MedPath

Impact of Music Therapy on Pain in Patients Treated for Advanced Cancer

Not Applicable
Completed
Conditions
Advanced Cancer
Interventions
Other: one music therapy session
Registration Number
NCT05315427
Lead Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Brief Summary

The aim of this study is to assess the impact of music therapy on the pain of patients cared at the Montpellier Cancer Institute (ICM) for advanced cancer in a palliative situation and requiring full hospitalization or on an outpatient basis.

Detailed Description

Music therapy is a care practice that falls within the field of support, help and accompaniment therapies. Sound, musical and music are the means used to support, maintain or improve a person's physical and mental health.

The patients involved in the study are patients cared at the ICM for advanced cancer in a palliative situation and requiring full hospitalization or on an outpatient basis.

The aim is to assess the impact of music therapy on the pain of these patients. The patient is proposed to participate in a music therapy session. Before this session, the music therapist will assess the pain and the presence of symptoms with the patient.

Following this exchange, she will define the device best suited to his expectations and his needs and will propose his a relaxation session induced by music.

After the session the music therapist will assess with the patient the pain and the presence of symptoms.

The patient's feelings and satisfaction about this music therapy session as well as his possible wish to participate in another session will also be evaluated.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria
  • Male/female over 18 years old
  • Patient cared for at the ICM for advanced cancer followed by the Mobile Palliative and/or Pain Care Team
  • Patient with pain score >= 3 (cancer related)
  • Patient who accepts a music therapy session
  • Patient having expressed his oral non-opposition
  • Patient able to communicate
  • Patient affiliated to the French Social Security System.
Exclusion Criteria
  • Patient with uncorrected hearing loss to normal
  • Patient under guardianship, curatorship or safeguard of justice

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Evaluation of the impact of music therapy on the pain of patientsone music therapy sessionOne music therapy session
Primary Outcome Measures
NameTimeMethod
Change between before and after music therapy session on patients painat day 1 (before and after the music therapy session)

Evolution of pain assessed by a numerical pain scale ranging from 0 to 10 (10 indicating the highest degree of pain)

Secondary Outcome Measures
NameTimeMethod
Patient wishing a second session of music therapyat day 1 (after the music therapy session)

Proportion of Patient wishing a second session of music therapy

Patient satisfaction of the music therapy sessionat day 1 (after the music therapy session)

Assessment of the satisfaction of the music therapy session. Assessment made by a numerical scale ranging from 0 to 10 (10 indicating high satisfaction)

Description of symptom managementat day 1 (before and after the music therapy session)

By the Edmonton Symptom Assessment System scale symptom score. This is a self-assessment scale of the most common symptoms in palliative care:pain, dyspnoea, fatigue, drowsiness, appetite, anxiety, depression, well-being and other possible symptoms. It's a numerical scale ranging from 0 to 10 (with higher scores indicating more severe symptoms).

The Edmonton Symptom Assessment System scale allows to:

* Detect the symptoms present, quantify them and follow their evolution

* Validate with the patient the symptoms that bother him and that he wishes to be treated as a priority

* Communicate quickly between the different professionals involved in the treatment.

Agreement to participate in the studyat inclusion

Proportion of patients agreeing to participate among the eligible patients to whom the study was proposed

Trial Locations

Locations (1)

Institut du Cancer de Montpellier

🇫🇷

Montpellier, France

© Copyright 2025. All Rights Reserved by MedPath